Clemastine fumarate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for clemastine fumarate and what is the scope of freedom to operate?
Clemastine fumarate
is the generic ingredient in three branded drugs marketed by Actavis Mid Atlantic, Apotex Inc, Genus, New Heights, Teva Pharms, Wockhardt Bio Ag, Novartis, Ani Pharms, L Perrigo Co, Pld Acquisitions Llc, Sandoz, Teva, and Haleon Us Holdings, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.Three suppliers are listed for this compound.
Summary for clemastine fumarate
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 13 |
NDAs: | 14 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 86 |
Clinical Trials: | 9 |
Patent Applications: | 6,533 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in clemastine fumarate? | clemastine fumarate excipients list |
DailyMed Link: | clemastine fumarate at DailyMed |
Recent Clinical Trials for clemastine fumarate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of California, San Francisco | Phase 1/Phase 2 |
United States Department of Defense | Phase 1/Phase 2 |
Amsterdam UMC, location VUmc | Phase 3 |